Peripheral artery disease in pseudoxanthoma elasticum: Walking capacity on the 6-minute walking test

• by Melanie Haverkamp, Frank LJ Visseren, Constantijn EVB Hazenberg, Pim A de Jong, Wilko Spiering

• June 11, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Catheter monitoring in intelligent endovascular navigation systems: interactive simulations and mixed reality for enhanced navigational awareness

• by Veronica Ruozzi, Giovanni Battista Regazzo, Maria Chiara Palumbo, Wim-Alexander Beckers, Mouloud Ourak, Xiu Zhang, Francesca Perico, Alessandro Caimi, Emmanuel Vander Poorten, Emiliano Votta

• June 9, 2026

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.

• by Kathryn Wighton

• June 22, 2026

• 3 min